GAS6

GAS6 Molekülinformation

Englischer Name	Growth arrest-specific protein 6	Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	1	Target-Alias	GAS6，AXLLG，Growth Arrest Specific 6，AXL Receptor Tyrosine Kinase Ligand，AXL Stimulatory Factor，Growth Arrest-Specific Protein 6，GAS-6，AXSF，FLJ34709，DKFZp666G247
Höchste Forschungs- und Entwicklungsphase	Phase 3 Clinical

Englischer Name	Growth arrest-specific protein 6
Target-Alias	GAS6，AXLLG，Growth Arrest Specific 6，AXL Receptor Tyrosine Kinase Ligand，AXL Stimulatory Factor，Growth Arrest-Specific Protein 6，GAS-6，AXSF，FLJ34709，DKFZp666G247
Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	1
Höchste Forschungs- und Entwicklungsphase	Phase 3 Clinical

GAS6 Produktliste

Attribut
Protein (3)
Produktbibliothek
Online (3)
Spezies
Human (3)
Etikett
His Tag (3)
Marker
Unconjugated (3)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Vorbestellen/Bestellen
HOT GA6-H5246	Human	HEK293	Human GAS6 (49-678) Protein, His Tag	In den Warenkorb legen
GA6-H5247	Human	HEK293	Human GAS6 (471-678) Protein, His Tag (MALS verified)	In den Warenkorb legen
GA6-H5249	Human	HEK293	Human GAS6 (279-678) Protein, His Tag (MALS verified)	In den Warenkorb legen

Gesamtmenge3

GAS6 Molekülhintergrund

GAS6 (Growth arrest-specific protein 6) is also known as AXL receptor tyrosine kinase ligand, AXLLG. Ligand for tyrosine-protein kinase receptors AXL, TYRO3 and MER whose signaling is implicated in cell growth and survival, cell adhesion and cell migration. GAS6/AXL signaling plays a role in various processes such as endothelial cell survival during acidification by preventing apoptosis, optimal cytokine signaling during human natural killer cell development, hepatic regeneration, gonadotropin-releasing hormone neuron survival and migration, platelet activation, or regulation of thrombotic responses.

GAS6 Molekülalias

GAS6,GAS-6,AXLLG

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
Batiraxcept	S6-500c; 3D-229; 3D229; 3D-299; Ruga-S6; AB-007; AVB 500; AVB-500; Aravive S-6; AVB-S6-500	Phase 3 Clinical	Aravive Inc	Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Fallopian Tube Neoplasms; Glomerulonephritis, IGA; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Solid tumours; Uterine Neoplasms	Details